ArticleTherapeutic advances in endocrinology and metabolism2021

Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-world data.

Taeang Arai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.